Related Experiment Videos

Pulmonary mucormycosis in diabetic renal allograft recipients

S Latif1, N Saffarian, K Bellovich

  • 1Department of Internal Medicine, St John Hospital and Medical Center, Detroit, MI 48236, USA.

Insights

Renal transplant patients on immunosuppression face risks of mucormycosis, a fungal infection. Early treatment with amphotericin B and surgery improved outcomes in two diabetic patients, preserving kidney function.

Area of Science:

  • Mycology
  • Transplant Medicine
  • Infectious Diseases

Background:

  • Renal allograft recipients require immunosuppression, increasing susceptibility to opportunistic infections.
  • Mucormycosis, a rare fungal infection caused by Mucorales, poses a life-threatening risk due to vascular invasion and dissemination.
  • Risk factors include diabetes, neutropenia, and iron/aluminum chelation therapy.

Observation:

  • Two cases of pulmonary mucormycosis in diabetic renal allograft recipients are presented.
  • Patients presented with opportunistic fungal infections post-transplantation.

Findings:

  • Successful treatment involved amphotericin B and surgical resection of lesions.
  • Allograft function was preserved following treatment.
  • Prompt diagnosis and aggressive therapy are crucial for improved outcomes.

Implications:

  • Increased incidence of mucormycosis may be observed in transplant populations due to intensified immunosuppression.
  • This highlights the importance of vigilance for mucormycosis in immunocompromised patients.
  • Aggressive management strategies are vital for managing this severe opportunistic infection in transplant recipients.

Related Concept Videos